Match Biosystems will introduce a new generation of in vitro diagnostic devices (IVD) able to improve current diagnostic times (< 1h, no sample pretreatment required) and sensitivity (> 90%). MATCH biosystems was born to make available the FASTEST and most RELIABLE solution in the IVD market.
Learn more
Learn more
Investors 1
| Date | Name | Website |
| - | BHVPartner... | bhvpartner... |
Mentions in press and media 2
| Date | Title | Description |
| 15.06.2022 | BHV Partners entra en el capital de Equilibrium Cosment | 15/06/2022 Nota de prensa BHV PARTNERS ENTRA EN EL CAPITAL DE EQUILIBRIUM COSMENT. BHV Partners, primer venture builder en salud del sur de Europa, ha añadido a su portfolio de startups participadas a la empresa Equilibrium Cosment, un c... |
| 30.11.2020 | Clave, a través de Tech Transfer UPV y BHV Partners, entran en el capital de MATCH biosystems | 30/11/2020 Nota de prensa CLAVE, A TRAVÉS DE TECH TRANSFER UPV Y BHV PARTNERS, ENTRAN EN EL CAPITAL DE MATCH BIOSYSTEMS. La gestora de capital de riesgo (venture capital) Clave, a través de Tech Transfer UPV, y BHV Partners han entrado e... |